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Introduction
The simultaneous occurrence of multiple vascular mal-
formations involving the orbit, brain and face is ex-
tremely rare. A review of the literature indicates that the
first case of retinal vascular malformation associated
with ipsilateral cerebral arteriovenous malformation
(AVM) was documented by Bonnet et al1 in 1937, then
it was further reviewed in detail by Wyburn-Mason 
in 1943.2 Since then, the Wyburn-Mason syndrome
(WMS) has been the nomenclature designated for a
distinct clinical entity comprising: (1) AVM of the mid-
brain; (2) congenital vascular abnormality of the ipsi-
lateral retina; (3) facial nervi; and (4) mental change.
Subsequent reports described single cases or small series
of patients associated with different locations and exten-
sions of AVMs in the craniofacial regions.3–5 The pur-
poses of this study are to report the imaging spectrum
of craniofacial vascular malformations in 14 patients
with WMS and to review the literature with emphasis
on the locations and distributions as well as types of
these vascular malformations.
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Methods: The medical records of 14 patients with the diagnosis of WMS who underwent neuroimaging studies (com-
puted tomography [CT], 8; magnetic resonance imaging [MRI], 12; conventional angiography, 14) were reviewed, empha-
sizing the location, extension and type of facial, orbital and brain vascular malformations. Complete WMS was defined
as vascular malformations involving all the 3 zones of the face, orbit and brain, while partial WMS was considered as
vascular malformation distributed in 2 zones.
Results: The craniofacial vascular malformations were confined on the left side in 7 patients, 2 were found on the right side,
while the remaining other 5 patients had midline brain AVMs involving both sides. All but 1 of these 14 patients had orbital
and/or brain AVMs; facial vascular malformations were documented in 5 patients. The most common site of involvement
was the optic nerve (n =12), followed by the retina (n =10), optic chiasma/hypothalamus (n =9), thalamus (n =7), basal
ganglion (n = 5), midbrain (n =2), occipital lobe (n =1), temporo-occipital lobe (n =1) and fronto-temporo-parieto-occipital
lobe (n=1). The complete form of WMS was found in 2 patients and the partial form in 12. CT, MRI and conventional angiog-
raphy have the capacity to demonstrate the extent of intracranial AVMs. However, MRI is superior to both CT and angiog-
raphy for detecting the size, extent of AVMs and the effects of AVMs on adjacent brain. Conventional angiography is
superior to both CT and MRI in determining the detailed angioarchitecture of AVMs.
Conclusion: WMS has a wide spectrum of multiple AVMs involving unilateral or bilateral craniofacial regions. The most
common involved site is the orbit, followed by the brain. WMS should be considered in patients with ocular AVMs associ-
ated with brain AVMs. [J Chin Med Assoc 2006;69(12):575–580]
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Methods
From 1982 to 2001, there were 1,826 patients with
brain AVMs who were referred for assessment or treat-
ment to the Department of Diagnostic and Interven-
tional Neuroradiology, Bicetre Hospital, Paris. Of these,
14 patients (9 men, 5 women; mean age, 19 years) were
found to meet the criteria for WMS. We retrospectively
reviewed the case records and imaging studies of these
patients. Initial neuroimaging studies consisted of com-
puted tomography (CT) in 8 patients and magnetic
resonance imaging (MRI) in 12 patients to determine
the size, type and location of vascular malformations.
Conventional 4-vessel angiographic studies were per-
formed in all 14 patients to delineate the spectrums of
vascular malformations in terms of angioarchitectures
(e.g. feeding artery and venous drains). All images were
reviewed by 2 neuroradiologists with experience in
cerebrovascular anatomy and angioarchitectures of vas-
cular malformation with emphasis placed on the loca-
tions and types of vascular malformations. In addition,
the management and outcome of these 14 patients were
retrospectively analyzed. As an aid to diagnosis, we
divided the involved areas into 3 zones: face, orbit
and brain, and employed the criteria that lesions must
be present in at least 2 of these zones for the diagnosis
to be made. In addition, the complete form of WMS
was defined as vascular malformations involving all 3
zones, while the partial form of WMS was defined as
vascular malformations involving 2 zones only.
Results
The findings of individual cases with the locations and
types of vascular malformations are summarized in
Table 1. The age of these patients when they presented
with symptoms (mean age, 19 years) was younger than
the age of patients with sporadic brain AVMs (mean
age, 40 years).6 The most common clinical manifesta-
tion in these 14 patients was decreased visual acuity
(n = 10), followed by neurologic deficit (n = 6), head-
ache (n=4), oronasal bleeding (n=3), intracranial hem-
orrhage (n=3), and seizure (n=2) (Table 1). Complete
WMS was found in 2 patients (Figure 1), while the
other 12 patients were grouped as having the partial
form of WMS (Figure 2). In terms of facial vascular
malformations, 5 patients had facial cutaneous lesions,
and 4 of them were verified to have underlying facial
vascular malformation (Figure 1E).
Table 1. Demographic characteristics of 14 patients with Wyburn-Mason syndrome
No/sex/
Clinical manifestation
Lesion Location of vascular malformation
age (yr) side Face Eye Brain
1/F/9 Decreased visual acuity, LT Yes Retina, optic nerve Optic chiasma, hypothalamus,
oronasal bleeding thalamus, basal ganglion, midbrain
2/M/4 Headache, seizure, LT No Optic nerve Optic chiasma, hypothalamus,
hemiparesis, ICH thalamus, occipital lobe
3/M/13 Decreased visual acuity, LT No Retina, optic nerve Thalamus, basal ganglion
epistaxis, headache
4/M/34 Hemiparesis, ICH LT No Retina, optic nerve Optic chiasma, hypothalamus
5/F/11 Hemiparesis LT Yes Retina Optic chiasma, hypothalamus,
thalamus, basal ganglion
6/F/13 Decreased visual acuity LT No Retina, optic nerve Optic chiasma, hypothalamus
7/M/49 Decreased visual acuity, ICH LT No Retina, optic nerve Optic chiasma, hypothalamus
8/M/7 Decreased visual acuity, RT No Retina, optic nerve Thalamus, basal ganglion, fronto-
headache, hemiparesis temporo-parieto-occipital lobe
9/F/14 Decreased visual acuity, RT No Retina, optic nerve Thalamus, basal ganglion,
hemiparesis, seizure temporo-occipital lobe
10/M/49 Epistaxis Midline Yes None Optic chiasma, hypothalamus
11/M/28 Decreased visual acuity, Midline Yes Retina, optic nerve Optic chiasma, hypothalamus,
headache occipital lobe
12/M/8 Decreased visual acuity, Midline No Optic nerve Thalamus
hemiparesis
13/M/16 Decreased visual acuity Midline No Optic nerve Optic chiasma, hypothalamus,
thalamus, midbrain
14/F/10 Decreased visual acuity Midline Yes Retina, optic nerve Nil
LT = left; RT = right; ICH = intracerebral hemorrhage.
All 14 patients had intracranial AVMs. The most
common site of intracranial AVM was the optic nerve
(n =12), followed by the retina (n =10), optic chi-
asma and hypothalamus (n=9), thalamus (n=7), basal
ganglion (n=5), midbrain (n=2), occipital lobe (n=1),
temporo-occipital lobe (n=1) and fronto-temporo-
parieto-occipital lobe (n = 1). Unilateral lesions were
found in 9 patients (right = 2, left = 7; Figure 2), while
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Figure 1. Images of a 28-year-old man with the complete form of Wyburn-Mason syndrome, involving the face, orbit and brain. (A) Axial
T2-weighted image shows arteriovenous malformations (AVMs) at the left orbit (arrow) and midline of the hypothalamus. (B, C, D)
Bilateral internal carotid angiograms demonstrate AVMs involving the left orbit and midline of the hypothalamus and thalamus, which
were supplied by the ophthalmic artery and perforating branches of the middle and anterior cerebral arteries, draining to the internal
cerebellar vein to the straight sinus. (E) Left external carotid angiogram depicts maxillary AVMs associated with aneurysmal formation
in the pterygopalatine segment of the internal maxillary artery (arrow).
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Figure 2. Images of a 7-year-old boy with the partial form of Wyburn-Mason syndrome, involving the right brain and orbit. (A, B) Right
carotid angiograms reveal diffuse arteriovenous malformations involving the right orbit, thalamus, basal ganglion and fronto-temporo-
parieto-occipital (FTPO) regions, supplied by the ophthalmic artery, perforating branches of the middle cerebral artery as well as its 
cortical branches of FTPO and draining to the superficial cortical veins and deep internal cerebral vein to the straight sinus.
midline lesions involving both sides were documented
in the remaining 5 patients (Figure 1). Regarding the
imaging studies, CT, MRI and conventional angiog-
raphy had the capacity to detect the distribution of
the vascular malformations. In general, CT and MRI
were superior to conventional angiography for demon-
strating the precise anatomic location of the AVM
nidi. MRI proved especially valuable for defining the
location of the AVM nidi with respect to the surface
of the brain, the ventricular system, and the corpus cal-
losum because of its capability of multiplanar images.
Conventional angiography was superior to both CT
and MRI for showing the exact feeding arteries and
draining vein of the vascular anomalies, as well as risk
factors of AVM such as flow-related or intranidal
aneurysm.
Seven patients who were referred for imaging con-
sultation were lost to follow-up after assessment. Seven
patients had received endovascular embolization in an
attempt to reduce the risk of bleeding or rebleeding
of the cerebrum (n =5) and oronasal region (n = 2);
all of these 7 patients were stable in the mean follow-up
period of 15 months (range, 5–37 months). Because
all intracranial AVMs were multiple and large as well
as deep-seated, no lesion was considered as morpholog-
ically curable by surgical removal, embolization or
radiosurgery alone or by combined modalities.
Discussion
Multiple brain AVMs are rare; in a review of 203
patients with brain vascular malformations, 9% of
patients could be included in the multiple AVMs cate-
gory and only 1 (0.4%) of them was considered to
have WMS.7 The exact etiology of this rare syndrome
is unknown. In its partial form, definite retinal involve-
ment is absent, in contrast to the classic form of the
syndrome as originally defined.8 Tsuneoka et al9 sub-
sequently further advocated that the incomplete form
of WMS be characterized as brain AVM, usually situ-
ated unilaterally in the thalamus, in association with
either retinal or intraorbital AVM. On the contrary, in
its extreme or complete form, intracranial AVMs can
extend forward, continuously, from the occipital or
parietal lobe and thalamus via the hypothalamus, optic
chiasm and optic nerve to the retina, with midbrain and
cerebellar involvement occasionally described. In our
series, only 2 patients (14%) had the complete form,
involving all 3 zones. Nevertheless, 44% of patients 
in Theron et al’s review were considered to have the
complete form;3 this was presumably due to an over-
looking of partial forms of WMS as sporadic AVMs.
The variable and broad spectrums of vascular mal-
formation of WMS are best understood by addressing
the embryologic relationship of the involved vessels.
In recent years, under the control of hox genes, seg-
mentation of the rhombencephalon into rhombomers
and forebrain analog into prosomeres has been substan-
tiated in birds, mice and other animals, and then in
humans.10,11 Hox gene-encoded positional informa-
tion in the neural crest cells is known to be involved
in patterning of the pharyngeal arches and is most
likely involved in determining neural crest cell distri-
bution among the arch-derived arteries such as brain,
orbit and face. Any inherent defect in these primitive
brains would likely affect their derivative tissues.
Therefore, there is a potential spectrum of metameric
craniofacial AVMs in those patients with dysgenesis of
primitive brains.12 The distribution of vascular malfor-
mation of partial or complete WMS depends largely
on the involved primitive brains. In the past, the lesions
were thought to be unilateral, being invariably ipsilat-
eral to the intracranial lesions, therefore Theron et al3
named the syndrome wrongly as “unilateral” retino-
cephalic vascular malformations. In fact, the AVMs
are not confined unilaterally; they can involve both
sides4 in midline location, as was demonstrated in 5
cases in our series.
Patients with WMS exhibit a variety of clinical man-
ifestations and various degrees of severity of vascular
malformation. In general, there are 3 types of clinical
manifestations: ocular, neurologic or facial. Ocular mani-
festations include decreased visual acuity, visual field
defect, proptosis and conjunctival injection caused by
spontaneous hemorrhage or ischemia or mass effect
with compression of the optic tract, chiasm or nerve.
Although retinal involvement is no longer considered
essential for the diagnosis of WMS, ocular manifes-
tations of AVMs in the retina and/or orbit remain
important clues for the diagnosis of this condition.
Among the 14 patients in our series, decreased visual
acuity was the most common symptom and was found
in 10 patients (71%); 93% of patients had orbital
(n = 12) and/or retina AVMs (n = 10). The retinal
and/or orbital lesions range from ophthalmoscopi-
cally barely visible vascular anomalies to large tangles
of tortuous and dilated vessels covering a substantial
portion of the retina. Therefore, when ocular AVMs
are recognized initially, a systematic neuroimaging
examination should be performed in search of a poten-
tial intracranial vascular lesion to exclude WMS.
A wide variety of neurologic manifestations of WMS
differing in site and extent of the cerebral lesions are
reported. The symptoms are related to the ruptured
AVMs with intracranial hemorrhage and/or mass
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effect of the AVMs. Headache, seizure and neurologic
deficit are the usual indicators of central nervous sys-
tem involvement, although the specific symptoms and
signs depend on the location and extent of the brain
AVM. The neurologic presentation of patients with
WMS may differ from those of patients with sporadic
brain AVMs. Mackenzie13 found that epilepsy (32%)
or hemorrhage (30%) was the most common presenting
complaint in 50 patients with sporadic brain AVMs,
whereas Theron et al3 reported that hemiparesis (50%)
was the most common presenting complaint in 27
patients with WMS; hemorrhage was only present in
12% and epilepsy appeared in 5%. In our series, the
most common neurologic symptoms were hemipare-
sis (43%), followed by headache (31%), hemorrhage
(21%) and seizure (14%). The decreased incidence of
seizure probably reflects the deep location of the brain
AVMs in WMS.
Maxillofacial cutaneous manifestations were found
in a minority of patients in this series as compared to
lesions of the orbit and brain. However, these facial
lesions may be the first signs to be detected because
of asymptomatic intracranial vascular malformations.
When present, such facial lesions vary from a faint
cutaneous discoloration to high-flow maxillofacial and/
or mandibular AVMs, which may present with life-
threatening hemorrhage in addition to severe cosmetic
and psychologic problems. When lesions of the max-
illa or mandible are found, angiographic studies should
be obtained to define the nature of vascular malfor-
mation and extension of the lesion. In addition, the
angiograms should include the brain to search for poten-
tial intracranial vascular malformations of WMS. In
our series, only 5 patients were detected as having
facial involvement, and this facial vascular anomaly
may be overlooked or ignored, particularly in those
patients with subtle change. In addition, facial vascu-
lar anomalies may be confused with neurocutaneous
syndromes or phakomatoses associated with neurovascu-
lar anomalies such as PHACE syndrome, Sturge-Weber
syndrome, tuberous sclerosis and neurofibromatosis.
Unlike WMS, which is associated with craniofacial
AVMs, PHACE syndrome is related to arterial anom-
aly of the extra- and intracranium.14 Sturge-Weber
syndrome is classified as a venous anomaly. Tuberous
sclerosis and neurofibromatosis are associated with
intracranial tumor growth.
CT, MRI, and the more recently developed high-
resolution magnetic resonance angiography are non-
invasive neuroradiologic screening tools for intra- and
extracranial lesions. In the present series, CT and MRI
provided useful information on the exact location and
extent of the AVMs and their relation to adjacent vital
structures such as the optic nerve and brain stem, and
could help guide the aggressiveness of any subsequent
therapy. Nonetheless, confirmation of the diagnosis
needs conventional angiography. For all the intracra-
nial or extracranial vascular lesions, 4-vessel cerebral
angiography is the only means of providing accurate
anatomic localization of the vascular malformations.
Moreover, knowledge of the extent, pattern, and num-
ber of the vessels feeding and draining the malforma-
tion as well as potential risk angioarchitectures such as
flow-related and/or intranidal aneurysms is needed in
planning the most suitable mode of therapy.
The management of this particular syndrome remains
controversial, and there are only a few reports in the
literature because its long-term prognosis and natural
history are unknown. In addition, most brain AVMs
of WMS are diffuse and deep-seated and are not usu-
ally amenable to direct surgical intervention due to the
significant postoperative neurologic sequelae. Therefore,
many physicians prefer to treat patients conservatively.
Surgical treatment of selecting suprasellar AVMs has
been reported to be associated with severe unilateral
vision loss.15,16 By far, less invasive endovascular emboli-
zation with partial treatment targeting a weak-point
angioarchitecture of AVMs, such as intranidal aneurysm,
is chosen in most cases. In our series, 7 patients coming
from abroad was lost to follow-up after image consul-
tation; 5 patients underwent endovascular emboliza-
tion of cerebral AVMs in an attempt to reduce the risk
of rebleeding (n=3) or bleeding (n=2). Two patients
with intractable oronasal bleeding were controlled by
endovascular procedure by infusing embolic particles
into the vascular malformation. In no case were the
intracranial AVMs considered to be morphologically
curable by surgical removal, embolization or radio-
surgery alone or by combined modalities.
In conclusion, WMS is associated with a wide
spectrum of multiple vascular malformations involving
unilateral or bilateral orbits, brain and/or face. These
spectrums of malformations can be determined by
CT, MRI and conventional angiography. Most
patients have the partial form of WMS that involves 2
zones of orbit, brain and/or face. The most common
involved sites are the orbit and brain, followed by the
face. WMS should be considered in patients with 
ocular AVM associated with brain or facial vascular
malformations.
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